〜It becomes a front-runner that ties to making to industry the sugar chain science.〜

Three businesses of the drug development support business (short term), the food business (middle term), and the drug development business (long term) develop in the pillar centering on the sugar chain science of which it is basic the sugar chain structure and analysis technologies and is the sugar chain science Nagoya bases(http://www.agr.nagoya-u.ac.jp/~kikan/sub4.html) of Nagoya City University.(http://www.phar.nagoya-cu.ac.jp/hp/sbk/)

�T）Drug development support business by sugar chain structure analysis and sugar chain reagent sales
Our the sugar chain structure and analysis technologies have confidence not to be defeated by nobody. A sugar chain structure analysis that promptly and was accurate was enabled by equipping it fully with abundant sugar chain data bases GALAXY to which other follows were not permitted and standard goods sugar chains. The sugar chain professional can be wholly filed, and the organization and the cell can be analyzed quantitatively and structuring. Therefore, the trust quality control that ascertains the difference of the sugar chain of the sugar protein product is skillful most, and our business base now. Moreover, it is possible that the sugar chain structure analysis that uses HPLC refines the sugar chain at the same time apart, and sells the sugar chain of making to PA. Those sugar chains become in the chip, and manufacturing the sugar chain chip made fixed seems to enter the closing phase, too and to become possible sales in the near future. These drug development support businesses are from research laboratories such as the pharmaceutical company, the food companies, and universities needs, and will do the business operation aggressively in the future.

�U）Sugar chain food business that precise sugar chain structure analysis and separation refinement technology enabled
A lot of sugar chains are included in the functional food, the legend food, and the food of the Chinese medicine etc.The sugar chain food of high purity can be offered from past food by ascertaining only the effective one by the sugar chain structure analysis among sugar chains that exist in them, and doing the separation refinement. We are researching the disease prevention food that pays attention to a certain sugar chain by a joint research now. I want to develop the food business greatly as the following stage of the drug development support business.

�V）Drug development business that connects seeds of sugar chain science Nagoya base departure with making to industry
We challenge "Sugar chain use type drug development" that achievement was difficult up to now by drawing up seeds of the sugar chain science Nagoya base where a lot of specialists of the sugar chain science exist. It does a joint research actively with each research laboratories, and the result is going out well now, too. Moreover, the biomarker or the diagnosis marker search of the disease by the sugar chain structure analysis is a forte, it succeeds in the discovery of the sugar chain that becomes the diagnosis marker of a certain disease, and the patent is being applied for. These businesses are made to succeed, and it aims at IPO in 2010.

It aims GLYENCE leading making of the sugar chain science research industry, and making Nagoya one large base (the sugar chain science research and industry) like this. And, it contributes to the world by the medicine development of which it is basic is the sugar chain science.